Your browser doesn't support javascript.
loading
Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021.
Fortunato, Francesca; Prato, Rosa; Iannelli, Giuseppina; Ascatigno, Leonardo; Loconsole, Daniela; Lopalco, Pier Luigi; Martinelli, Domenico.
Afiliación
  • Fortunato F; Hygiene Unit, Policlinico Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Prato R; Hygiene Unit, Policlinico Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Iannelli G; Hygiene Unit, Policlinico Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Ascatigno L; Hygiene Unit, Policlinico Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Loconsole D; Hygiene Section, Department of Interdisciplinary Medicine, University of Bari, Bari, Italy.
  • Lopalco PL; Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy.
  • Martinelli D; Hygiene Unit, Policlinico Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Hum Vaccin Immunother ; 19(1): 2209919, 2023 12 31.
Article en En | MEDLINE | ID: mdl-37226552
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Italia